Cargando…

Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?

INTRODUCTION: The relationship between cardiovascular disease (CVD) and lower urinary tract symptoms (LUTS) is well established. A healthy lifestyle with a good quality diet and regular physical activity is important for reducing the severity of LUTS. MATERIAL AND METHODS: A literature search was pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Semczuk-Kaczmarek, Karolina, Płatek, Anna E., Szymański, Filip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203768/
https://www.ncbi.nlm.nih.gov/pubmed/32395322
http://dx.doi.org/10.5173/ceju.2020.0029
_version_ 1783529930241343488
author Semczuk-Kaczmarek, Karolina
Płatek, Anna E.
Szymański, Filip M.
author_facet Semczuk-Kaczmarek, Karolina
Płatek, Anna E.
Szymański, Filip M.
author_sort Semczuk-Kaczmarek, Karolina
collection PubMed
description INTRODUCTION: The relationship between cardiovascular disease (CVD) and lower urinary tract symptoms (LUTS) is well established. A healthy lifestyle with a good quality diet and regular physical activity is important for reducing the severity of LUTS. MATERIAL AND METHODS: A literature search was performed on the subject of association between LUTS and cardiovascular risk. RESULTS: The recent data indicates that therapy for cardiovascular risk reduction might also reduce the severity of LUTS (e.g. statins reduce the risk of benign prostatic hyperplasia [BPH] and slow down the progression of LUTS in patients with hyperlipidaemia). Hypertensive patients treated with angiotensin II receptor blockers have a lower severity of LUTS. This paper shortly discusses the relationship between the occurrence of LUTS and CVD and the potential clinical implications regarding the management of the patients. CONCLUSIONS: Patients with lower urinary tract symptoms require a holistic approach and cooperation of a urologist and cardiologist to diagnose concomitant cardiovascular diseases as early as possible and implement appropriate treatment. Antihypertensive, antithrombotic, hypolipemic therapies and healthy lifestyles reduce not only cardiovascular mortality, but also might reduce the severity of LUTS.
format Online
Article
Text
id pubmed-7203768
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Polish Urological Association
record_format MEDLINE/PubMed
spelling pubmed-72037682020-05-11 Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? Semczuk-Kaczmarek, Karolina Płatek, Anna E. Szymański, Filip M. Cent European J Urol Review Paper INTRODUCTION: The relationship between cardiovascular disease (CVD) and lower urinary tract symptoms (LUTS) is well established. A healthy lifestyle with a good quality diet and regular physical activity is important for reducing the severity of LUTS. MATERIAL AND METHODS: A literature search was performed on the subject of association between LUTS and cardiovascular risk. RESULTS: The recent data indicates that therapy for cardiovascular risk reduction might also reduce the severity of LUTS (e.g. statins reduce the risk of benign prostatic hyperplasia [BPH] and slow down the progression of LUTS in patients with hyperlipidaemia). Hypertensive patients treated with angiotensin II receptor blockers have a lower severity of LUTS. This paper shortly discusses the relationship between the occurrence of LUTS and CVD and the potential clinical implications regarding the management of the patients. CONCLUSIONS: Patients with lower urinary tract symptoms require a holistic approach and cooperation of a urologist and cardiologist to diagnose concomitant cardiovascular diseases as early as possible and implement appropriate treatment. Antihypertensive, antithrombotic, hypolipemic therapies and healthy lifestyles reduce not only cardiovascular mortality, but also might reduce the severity of LUTS. Polish Urological Association 2020-03-23 2020 /pmc/articles/PMC7203768/ /pubmed/32395322 http://dx.doi.org/10.5173/ceju.2020.0029 Text en Copyright by Polish Urological Association http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Review Paper
Semczuk-Kaczmarek, Karolina
Płatek, Anna E.
Szymański, Filip M.
Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
title Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
title_full Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
title_fullStr Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
title_full_unstemmed Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
title_short Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
title_sort co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203768/
https://www.ncbi.nlm.nih.gov/pubmed/32395322
http://dx.doi.org/10.5173/ceju.2020.0029
work_keys_str_mv AT semczukkaczmarekkarolina cotreatmentoflowerurinarytractsymptomsandcardiovasculardiseasewheredowestand
AT płatekannae cotreatmentoflowerurinarytractsymptomsandcardiovasculardiseasewheredowestand
AT szymanskifilipm cotreatmentoflowerurinarytractsymptomsandcardiovasculardiseasewheredowestand